Closing the Gap in Care in Seronegative Inflammatory Arthritis (Metrix II)
Primary Purpose
SpA, PsA
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Education and Feedback
Sponsored by

About this trial
This is an interventional diagnostic trial for SpA focused on measuring Seronegative Inflammatory Arthritis, SpA, PsA, Randomized, Behavioural Change
Eligibility Criteria
Inclusion Criteria:
- Canadian Rheumatologist
Exclusion Criteria:
Sites / Locations
- Dr. Vandana Ahluwalia
- Dr. Sanjay Dixit
- Dr Pauline Boulos
- Dr. Nikhil Chopra
- Dr Angela Montgomery
- Credit Valley Rheumatology
- The Medical Centre
- Sunnybrook Health Sciences Centre
- Dr. Arthur Karasik
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
No education or feedback
Education and Feedback
Arm Description
Rheumatologists randomized to this treatment arm receive no additional education or feedback about their systematic assessments of patients
Rheumatologists randomized to receive education and feedback participate in six web conferences designed to improve their systematic assessments of their patients, and are given feedback about their performances
Outcomes
Primary Outcome Measures
Improvement of Systematic Assessments
Physicians in the Education and Feedback arm are assessed via a needs assessment to identify the care gaps for their patients with inflammatory arthritis. After the education and feedback, they complete a second chart audit and their improvements in assessments is recorded.
Secondary Outcome Measures
Full Information
NCT ID
NCT01749618
First Posted
November 6, 2012
Last Updated
April 5, 2017
Sponsor
Pope Research Corporation
Collaborators
Academic Medical Organization of Southwestern Ontario, Abbott
1. Study Identification
Unique Protocol Identification Number
NCT01749618
Brief Title
Closing the Gap in Care in Seronegative Inflammatory Arthritis
Acronym
Metrix II
Official Title
Closing the Gap in Care in Seronegative Inflammatory Arthritis: From Identification to Implementation of Treating to Target: A Randomized Trial of Feedback, Education, and Behavioural Change
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
November 2012 (undefined)
Primary Completion Date
November 2016 (Actual)
Study Completion Date
November 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Pope Research Corporation
Collaborators
Academic Medical Organization of Southwestern Ontario, Abbott
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
SpA, PsA
Keywords
Seronegative Inflammatory Arthritis, SpA, PsA, Randomized, Behavioural Change
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
No education or feedback
Arm Type
No Intervention
Arm Description
Rheumatologists randomized to this treatment arm receive no additional education or feedback about their systematic assessments of patients
Arm Title
Education and Feedback
Arm Type
Experimental
Arm Description
Rheumatologists randomized to receive education and feedback participate in six web conferences designed to improve their systematic assessments of their patients, and are given feedback about their performances
Intervention Type
Behavioral
Intervention Name(s)
Education and Feedback
Intervention Description
Rheumatologists are rated on how systematically they assess their patients, and receive six sessions of university accredited education about systematic assessments of patients with seronegative arthritis.
Primary Outcome Measure Information:
Title
Improvement of Systematic Assessments
Description
Physicians in the Education and Feedback arm are assessed via a needs assessment to identify the care gaps for their patients with inflammatory arthritis. After the education and feedback, they complete a second chart audit and their improvements in assessments is recorded.
Time Frame
November 2012 - November 2013
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Canadian Rheumatologist
Exclusion Criteria:
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janet E Pope, MD, MPH, FRCPC
Organizational Affiliation
Pope Research Corp., St. Joseph's Health Care, Western University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dr. Vandana Ahluwalia
City
Brampton
State/Province
Ontario
Country
Canada
Facility Name
Dr. Sanjay Dixit
City
Burlington
State/Province
Ontario
ZIP/Postal Code
L7L 0B7
Country
Canada
Facility Name
Dr Pauline Boulos
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 1Y2
Country
Canada
Facility Name
Dr. Nikhil Chopra
City
London
State/Province
Ontario
ZIP/Postal Code
N6B 2E8
Country
Canada
Facility Name
Dr Angela Montgomery
City
Mississauga
State/Province
Ontario
ZIP/Postal Code
L5B 2P7
Country
Canada
Facility Name
Credit Valley Rheumatology
City
Mississauga
State/Province
Ontario
ZIP/Postal Code
L5M 2V8
Country
Canada
Facility Name
The Medical Centre
City
Peterborough
State/Province
Ontario
ZIP/Postal Code
K9J 7B3
Country
Canada
Facility Name
Sunnybrook Health Sciences Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4N 3M5
Country
Canada
Facility Name
Dr. Arthur Karasik
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M9C 5N2
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Closing the Gap in Care in Seronegative Inflammatory Arthritis
We'll reach out to this number within 24 hrs